ABVX
Abivax SA American Depositary Shares
NASDAQ: ABVX · HEALTHCARE · BIOTECHNOLOGY
$106.24
-3.30% today
Updated 2026-04-29
Market cap
$8.42B
P/E ratio
—
P/S ratio
1,843.30x
EPS (TTM)
$-5.66
Dividend yield
—
52W range
$6 – $149
Volume
1.0M
Abivax SA American Depositary Shares (ABVX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.31M | $-14.90M | $-15.61M | $-8.45M | $-14.60M | $-27.47M | $-29.82M | $-45.66M | $-53.94M | $-100.01M | $-154.07M | $-155.69M |
| Capital expenditures | $43185.00 | $1.02M | $721000.00 | $979000.00 | $763000.00 | $941000.00 | $898000.00 | $1.64M | $323000.00 | $265000.00 | $643000.00 | $136396.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | $828000.00 | $-1.16M | $8.18M | $20.22M | $35.40M |
| Free cash flow | $-3.35M | $-15.93M | $-16.33M | $-9.43M | $-15.37M | $-28.41M | $-30.72M | $-47.30M | $-54.26M | $-100.27M | $-154.72M | $-155.83M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |